What can be achieved?
Pharmacokinetics of drug and metabolites in different regions of the lungs
Research and identification of unknown metabolites related to efficacy or toxicity events
Untargeted differenial analysis in eyes to discover potential biomarkers
Study different form of drug administration and the impact into the localization (aerosol, dry powder, etc…)
What are our advantages?
Quantify drug and metabolites in different parts of the lung
Ability to overlay both molecular and spatial information
Efficacy and safety biomarkers monitoring
High resolution Mass Spectrometers (R>200,000)
"Your commitment to quality of work and meeting deadlines is excellent!"
"Imabiotech offered us the unique possibility to follow our lead that we could not label radiochemically"